Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)vsMcKesson Corporation (MCK)
HKPD
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
$0.49
-2.06%
HEALTHCARE · Cap: $9.28M
MCK
McKesson Corporation
$775.66
+2.47%
HEALTHCARE · Cap: $91.29B
Smart Verdict
WallStSmart Research — data-driven comparison
McKesson Corporation generates 2465884% more annual revenue ($403.43B vs $16.36M). MCK leads profitability with a 1.2% profit margin vs -4.3%. MCK earns a higher WallStSmart Score of 53/100 (C-).
HKPD
Avoid27
out of 100
Grade: F
MCK
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HKPD.
Margin of Safety
-65.1%
Fair Value
$577.34
Current Price
$775.66
$198.32 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Earnings expanding 37.2% YoY
Generating 3.3B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 3.0%
Weak financial health signals
ROE of -17.2% — below average capital efficiency
Expensive relative to growth rate
ROE of 0.0% — below average capital efficiency
1.2% margin — thin
Operating margin of 2.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : HKPD
The strongest argument for HKPD centers on Price/Book, Altman Z-Score.
Bull Case : MCK
The strongest argument for MCK centers on Debt/Equity, Altman Z-Score, Market Cap.
Bear Case : HKPD
The primary concerns for HKPD are Market Cap, Operating Margin, Piotroski F-Score.
Bear Case : MCK
The primary concerns for MCK are PEG Ratio, Return on Equity, Profit Margin. Thin 1.2% margins leave little buffer for downturns.
Key Dynamics to Monitor
HKPD profiles as a turnaround stock while MCK is a value play — different risk/reward profiles.
MCK is growing revenue faster at 6.0% — sustainability is the question.
MCK generates stronger free cash flow (3.3B), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MCK scores higher overall (53/100 vs 27/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Hong Kong Pharma Digital Technology Holdings Limited is a pioneering entity in the biotechnology and digital healthcare sectors, focused on enhancing patient outcomes through innovative pharmaceutical services. By harnessing cutting-edge digital technologies and sophisticated data analytics, the company optimizes drug development and boosts operational efficiencies, positioning itself as a key player in the dynamic healthcare landscape. With a commitment to health technology advancement and strategic collaborations, Hong Kong Pharma is well-equipped to meet the evolving needs of both domestic and international markets while propelling innovation within its extensive service offerings.
McKesson Corporation
HEALTHCARE · MEDICAL DISTRIBUTION · USA
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?